MedTrace Logo

Blood Loss Assessment in the Limited Application of Tourniquet During Primary Unilateral TKA

NCT05691751 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2023-10-24

No results posted yet for this study

Summary

Tourniquet application in total knee arthroplasty has many benefits and might have a role in the incidence of peri-operative complications the aim of this research: is to look into the effectiveness of the limited application of tourniquet during primary unilateral total knee arthroplasty and compare the perioperative complications with the standard full-time application.

Conditions

  • Arthritis Knee
  • Blood Loss
  • Arthroplasty Complications

Interventions

PROCEDURE

primary unilateral total knee arthroplasty with limited application of tourniquet

the tourniquet will be applicated around the proximal thigh in all patients before the incision, all patients will undergo primary unilateral TKA by the same surgeon using the medial para-patellar approach, and the prostheses used in all patients will be cruciate scarifying cemented DePuy Synthes PFC Sigma without resurfacing of the patella, intramedullary guides will be used for the femoral and tibial cuts as seen appropriate by the surgeon, however, the application time of the tourniquet during surgery will be as the allocation of each patient imply.

PROCEDURE

primary unilateral total knee arthroplasty with full application of tourniquet

the tourniquet will be applicated around the proximal thigh in all patients before the incision, all patients will undergo primary unilateral TKA by the same surgeon using the medial para-patellar approach, and the prostheses used in all patients will be

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • jaber ibrahim, MD PHD · Damascus university - faculty of medicine - department of surgery

  • hakam alasaad, MD · Damascus university - faculty of medicine - department of surgery

  • doried Diri, MD · Damascus university - faculty of medicine - department of surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-08-23
Completion
2022-08-23

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05691751 on ClinicalTrials.gov